Could this diabetes medication be the secret to avoiding cancer?
Patients with type 2 diabetes taking GLP-1 treatments, which include Ozempic, have a lower chance of developing 10 types of obesity-related cancers than those taking insulin and other diabetes drugs, according to a study published on Friday. GLP-1 treatments for type 2 diabetes have been on the market for nearly 20 years. The newer generation […]
Continue Reading